Aragen partners with Skyhawk Therapeutics to develop novel small molecule therapeutics

By: |
Updated: July 16, 2021 4:03 PM

Hyderabad based Contract Research and Development Organization (CRDO) Aragen Life Sciences (formerly, GVK BIO) has announced that it has been selected by Skyhawk Therapeutics, a leader in the development of small molecule therapeutics that correct RNA expression, as its partner in India.

aragenAragen Life Sciences Pvt Ltd (Aragen) is a global leader in providing discovery, development and manufacturing solutions for life sciences firms.

Hyderabad based Contract Research and Development Organization (CRDO) Aragen Life Sciences (formerly, GVK BIO) has announced that it has been selected by Skyhawk Therapeutics, a leader in the development of small molecule therapeutics that correct RNA expression, as its partner in India. Through this collaboration, Aragen will provide Skyhawk with various discovery chemistry and biology service solutions.

This partnership is focused on accelerating Skyhawk’s research pipeline. “We are delighted to have been selected by Skyhawk Therapeutics as its partner in India. At Aragen, we believe that in every molecule there is the possibility for better health. It is with this spirit that we look forward to leveraging Aragen’s 20 years of discovery research expertise to help Skyhawk advance the development of its novel small molecule therapeutics targeting some of the world’s most intractable diseases,” said Manni Kantipudi, CEO of Aragen.

Manni KantipudiManni Kantipudi, CEO of Aragen

Aragen Life Sciences Pvt Ltd (Aragen) is a global leader in providing discovery, development and manufacturing solutions for life sciences firms. With a team of over 3100 professionals, and through a network of sites around the world, it offers a seamless, integrated platform to advance customer programs from discovery through commercialization for both small molecules and biologics. Established in 2001, Aragen now serves over 450 customers worldwide across multiple modalities and therapeutic areas.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Delhi records zero COVID-19 fatality, fifth time since onset of 2nd wave of pandemic; 67 cases
2Delhi govt caps Covid RT-PCR test rate in pvt labs, hospitals at Rs 500; antigen test to cost Rs 300
3Head of UN health agency seeks vaccine booster moratorium